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A B S T R A C T
Nanographene oxide (nGO)-mediated hyperthermia has been increasingly investigated as a localized, minimally
invasive anticancer therapeutic approach. Near InfraRed (NIR) light irradiation for inducing hyperthermia is par-
ticularly attractive, because biological systems mostly lack chromophores that absorb in this spectral window, fa-
cilitating the selective heating and destruction of cells which have internalized the NIR absorbing-nanomaterials.
However, little is known about biological effects accompanying nGO-mediated hyperthermia at cellular and mol-
ecular levels. In this work, well-characterized pegylated nGO sheets with a hydrodynamic size of 300nm were
incubated with human Saos-2 osteosarcoma cells for 24h and their internalization verified by flow cytometry
and confocal microscopy. No effect on cell viability was observed after nGO uptake by Saos-2 cells. However, a
proliferation delay was observed due to the presence of nGO sheets in the cytoplasm. ⁠1H NMR metabolomics was
employed to screen for changes in the metabolic profile of cells, as this could help to improve understanding of
cellular responses to nanomaterials and provide new endpoint markers of effect. Cells internalizing nGO sheets
showed noticeable changes in several metabolites compared to control cells, including decreased levels of several
amino acids, taurine and creatine and increased levels of phosphocholine and uridine/adenosine nucleotides. Af-
ter NIR irradiation, cells showed decreases in glutamate and uridine nucleotides, together with increases in glyc-
erophosphocholine and adenosine monophosphate. Overall, this study has shown that the cellular metabolome
sensitively responded to nGO exposure and nGO-mediated hyperthermia and that NMR metabolomics is a pow-
erful tool to investigate treatment responses.
1. Introduction
The development of alternative and/or complementary therapeu-
tic strategies that can efficiently eliminate tumor cells without caus-
ing major deleterious side effects is a crucially important goal
in the fight against cancer [1–6]. Tumor destruction through nano-
material-mediated hyperthermia has been increasingly investigated as
a minimally invasive alternative to surgery, as well as to treat tu-
mors embedded in vital regions where surgical resection is not fea-
sible [7,8]. In this type of therapy, an energy-absorbing nanosystem
localized within tumor tissues absorbs energy provided
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by an external source and converts it into heat, thereby inducing local-
ized thermal destruction (above 40°C) without affecting the surround-
ing tissues, which have not taken up the nanomaterial [9–11]. The use
of Near Infrared (NIR) light in the 700–1100nm range for inducing tu-
mor hyperthermia is particularly attractive, because biological systems
mostly lack chromophores that absorb in this spectral window, facilitat-
ing the selective heating and destruction of cells which have internal-
ized the NIR absorbing-nanomaterials [12–14].
Several nanomaterials are being developed for use in nanotechnol-
ogy-based hyperthermia methods [15–20]. Nanosized graphene, partic-
ularly graphene oxide (nGO), represents one of the most thrilling candi-
dates for this application, especially due to its strong NIR optical absorp-
tion ability [21–23]. Moreover, nGO has other fascinating properties
which make it exquisitely suitable for nanomedicine applications, such
as excellent aqueous processability, amphiphilicity, Surface Enhanced
Raman Scattering (SERS) property, and fluorescence quenching ability
[24].
Nanographene oxide-mediated hyperthermia has been studied in
vitro [25–27] and in vivo [28,29]. It is known that depending on the laser
fluency, different temperature increments and various thermodynamic
and thermo-biological responses can occur in the tissue medium [30].
However, there is still limited understanding of the biological effects ac-
companying nGO-mediated hyperthermia at the cellular and molecular
levels. For instance, to our knowledge, no data concerning the meta-
bolic changes produced in tumor cells by nGO-mediated hyperthermia
have been described so far. The cellular metabolome (inventory of small
molecules acting as substrates/products of enzyme-mediated reactions)
closely reflects biochemical activity and functional status, being cur-
rently recognized as a key player in the cellular response to external
stimuli such as nanomaterials [31,32]. Hence, the ability to comprehen-
sively describe multiple metabolite changes (in a single analytical run)
is expected to provide improved understanding of biological processes,
compared to conventional single endpoint readouts. ⁠1H NMR is exquis-
itely useful in metabolomics due to its unparalleled analytical repro-
ducibility and ability to provide unequivocal structural and quantitative
information on a wide range of metabolites. Indeed, all proton-contain-
ing small molecules at submillimolar concentrations may potentially be
detected in complex biological samples (such as cells, tissues or bioflu-
ids), distinguished based on their chemical shifts and multiplicities, and
quantified based on signal areas [33].
In the present study, well-characterized pegylated nGO sheets (size
of 300nm) were incubated with human Saos-2 osteosarcoma cells for
24h and their internalization verified, along with the impact on cell via-
bility and proliferation. Saos-2 osteosarcoma cells have been selected as
a human tumor cell model due to their highly conserved properties. In-
deed, this cell line has been previously used in a large variety of in vitro
studies with nanomaterials based on its osteoblastic features, such as ex-
pression of collagen type I and type III, production of mineralized ma-
trix, high alkaline phosphatase levels, PTH receptors coupled to adeny-
late cyclase and presence of osteonectin (OC), bone sialoprotein (BSP)
and procollagen-I [34–36]. ⁠1H NMR analysis of lysed cell pellets was
employed to assess the changes in the cellular metabolome induced by
nGO uptake and subsequent laser irradiation (1.5W/cm⁠2 power, 5min).
This approach is expected to help improving current understanding of
cellular responses to nGO-mediated hyperthermia and to provide poten-
tial endpoint markers of effect.
2. Materials and methods
2.1. Synthesis and characterization of pegylated nGO sheets
Pegylated nGO sheets have been obtained from exfoliation of
high-purity graphite in an acidic medium by a modified Hummers
method, as previously reported [37]. The resulting nGO suspension
was dialyzed until pH7, and activated with chloroacetic acid
(Cl–CH⁠2–COOH) under strongly basic conditions (NaOH) to pro-
mote−COOH groups at the surface. Then, it was functionalized by
covalent bonding (diimide activation by adding EDAC:1-Ethyl-3-(3-di-
methylaminopropyl) carbodiimide hydrochloride) with the non-toxic
and non-immunogenic polymer Poly(Ethylene Glycolamine)(PEG) to
improve coloidal stability and minimize immunogenicity. Finally, nGO
sheets linked to 1-arm PEG were marked with the amine reactive dye
fluorescein isothiocyanate (FITC) covalently bonded to the PEG. The re-
sulting samples were analyzed by Atomic Force Microscopy AFM mul-
timode Nanoscope III A (Bruker). Dynamic light scattering (DLS) mea-
surements were also performed in pH5 solutions in a Zetasizer Nano
series instrument equipped with a 633nm “red” laser from Malvern In-
struments, with reproducibility being verified by collection and com-
parison of sequential measurements. Z-average sizes of three sequential
measurements were collected at room temperature (RT) and analyzed.
X-ray Photoelectron Spectroscopy (XPS) spectra were acquired in an Ul-
tra High Vacuum (UHV) system with a base pressure of 2×10⁠−10 mbar.
nGO-PEG powder was dispersed in MQ H⁠2O and drop coated on a Si
wafer. The system is equipped with a hemispherical electron energy an-
alyzer (SPECS Phoibos 150), a delay-line detector and a monochromatic
AlKα (1486.74eV) X-ray source. High resolution spectra were recorded
at normal emission take-off angle and with a pass-energy of 20eV,
which provides an overall instrumental peak broadening of 0.5eV. The
XPS spectra were calibrated in binding energy by referencing to the first
component of the C 1s spectrum to 284.8eV.
2.2. Cell culture for nGO uptake and cell proliferation studies
Human Saos-2 osteoblasts were seeded at a density of 10⁠5cells/mL
in DMEM culture medium supplemented with 10% FBS, 1mMl-glut-
amine, penicillin, streptomycin, under a 5% CO⁠2 atmosphere and at
37°C for 24h. After this time, 75μg/mL of nGO material were added
to the medium and the cells were cultured for 24h in contact with
nGO suspension. This concentration was chosen based on previous re-
sults whereby Saos-2 cells were found to rapidly internalize nGO and
to maintain high cell viability at this exposure level [38]. Then, the at-
tached cells were harvested with 0.25% trypsin-EDTA and counted with
a Neubauer hemocytometer, using trypan blue for assessing viability.
For assessing nGO cellular uptake, the fluorescence of nGO-FITC was ex-
cited at 488nm and measured with a 530/30band pass filter in an At-
tune® Acoustic Focusing Cytometer (ThermoFisher Scientific, Waltham,
MA). The conditions for data acquisition and flow cytometric analysis
were established using negative and positive controls and these condi-
tions were maintained during all the experiments. Each experiment was
carried out three times and single representative experiments are dis-
played. For statistical significance, at least 10⁠5 cells were analyzed in
each sample and the mean fluorescence emitted by these single cells was
estimated from the mean fluorescence intensity (MFI) of FITC using the
FlowJo software (Tree Star Inc., Ashland, OR, USA).
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2.3. Confocal microscopy studies
Cells were seeded on glass coverslips and cultured in the presence
of pegylated nGO material for 24h, fixed with 3.7% paraformaldehyde
in PBS, permeabilizated with 0.1% Triton X-100 and preincubated with
PBS containing 1% BSA. Then, cells were incubated for 20min with
rhodamine-phalloidin (1:40), stained with 40–6-diamidino-20-phenylin-
dole (DAPI, 3×10⁠−6M in PBS) and examined using a LeicaSP2 Con-
focal Laser Scanning Microscope. Rhodamine fluorescence was excited
at 540nm and measured at 565nm. DAPI fluorescence was excited at
405nm and measured at 420–480nm.
2.4. NIR laser irradiation
NIR radiation was provided by a high-power (30W) diodelaser (LAS-
ING S.A.) emitting in 808nm, giving a circular irradiation area of di-
ameter 3cm (fluency: 4Jcm⁠−2). The module allows irradiation of cul-
ture plates in a sterile environment. Irradiation was performed after
nGO–cell uptake which, based on previous results, was considered com-
plete after 24h of Saos-2 exposure to nGO solution. Laser irradiation
was performed at 1.5W/cm⁠2 power during 5min, based on previously
reported results [30]. Immediately (3min) after laser irradiation, cells
were harvested using 0.25% trypsin–EDTA, washed with deuterated PBS
(pH7.4), centrifuged (1000g, 6min, 4°C), re-suspended in 40μL PBS/
D⁠2O, and stored at −80°C until Nuclear Magnetic Resonance (NMR)
analysis.
2.5. NMR analysis
Thawed cells were mechanically lysed by a three-fold cycle of ni-
trogen freezing and sonication [39], and 50μL of each sample were
transferred into a High Resolution Magic Angle Spinning (HR-MAS) ro-
tor. NMR spectra were acquired on a Bruker Avance DRX-500 spec-
trometer operating at 500.13MHz for ⁠1H observation, at 277K, us-
ing a 4mm HRMAS probe, in which the rotor containing the sam-
ple was spun at 4kHz. To attenuate broad signals of macromolecules
and improve the detection of small metabolites, the T2-edited Carr-Pur-
cell-Meiboom-Gill spin-echo pulse sequence with water presaturation
(“cpmgpr1d” in Bruker library) was employed, using a total spin echo
time of 60ms (n=150, τ=200μs). Each 1D spectrum was acquired
with 2048 transients, 32k data points, a spectral width of 6510.42Hz,
a relaxation delay of 2s, and an acquisition time of 2.5s. Spectra were
processed with a line broadening of 0.3Hz and zero-filling factor of
2, manually phased and baseline corrected. Chemical shifts were ref-
erenced internally to the alanine signal at δ 1.48ppm. Spectral assign-
ment was based on 2D total correlation spectroscopy (TOCSY) and het-
eronuclear single quantum coherence (HSQC) spectra and consultation
of spectral databases, such as the Bruker Biorefcode database and the
human metabolome HMDB database [40].
2.6. Multivariate analysis and integration of NMR data
Data matrices of total area-normalized spectra were built in
Amix-viewer (version 3.9.14, Bruker Biospin, Rheinstetten) and mul-
tivariate analysis (MVA) was performed in SIMCA-P11.5 (Umetrics,
Sweden). Principal component analysis (PCA) was followed by par-
tial least square discriminant analysis (PLS-DA), whereby a 7-fold in-
ternal cross-validation was applied to assess the explained variance
(R⁠2) and predictive power (Q⁠2). The corresponding load
ings were obtained by multiplying the loading weight (w) by the stan-
dard deviation of each variable, and were color-coded according to vari-
able importance to the projection (VIP).
To assess the magnitude of metabolite variations, selected spectral
peaks were integrated in Amix-viewer, and normalized by the total area
of each spectrum (excluding the suppressed water signal). For each
metabolite, the magnitude of variation in nGO-treated/laser irradiated
samples relatively to controls was assessed by calculating the effect size
(ES), adjusted for small sample numbers, and respective standard error,
according to the equations provided in the literature [41]. The meta-
bolic changes with absolute ES larger than 0.8 (and with standard er-
ror<ES) were represented graphically and the two-sample t-test (95%
confidence level) was used to assess statistical significance of variations.
2.7. Statistics
Data are expressed as means±standard deviations of a represen-
tative of three experiments carried out in triplicate. Statistical analy-
sis was performed using the Statistical Package for the Social Sciences
(SPSS) version 19 software. Statistical comparisons were made by analy-
sis of variance (ANOVA). Scheffé test was used for post hoc evalua-
tions of differences among groups. In all of the statistical evaluations,
p<0.05 was considered as statistically significant.
3. Results and discussion
3.1. Synthesis and characterization of pegylated nGO sheets
Nanographene oxide (nGO) sheets, successfully obtained by the
modified Hummers' method, were characterized by AFM, XPS, zeta-po-
tential (ζ) and DLS particle size analysis. The chemical exfoliation of
graphite in aqueous media, followed by chemical activation and size
separation by centrifugation, resulted in pegylated nGO sheets having
an average thickness of around 9nm, corresponding to 13–14 layers
(Fig. 1A). Moreover, these nGO sheets had a hydrodynamic size distrib-
ution in the 200–550nm range, with the largest number of nanosheets
presenting sizes around 300nm, as shown by DLS data (Fig. 1B). Pegy-
lated nGO sheets were also characterized by XPS to study the elemental
composition and chemical environment of the elements present within
their surface. Fig. 1C shows a fitted C 1s spectrum, composed by four
components centered at: 284.8eV (C C/C C), 286.3eV (C O/C
N), 287.7eV (C O) and 288.9eV (O C O/N C=O). In general,
the treatment carried out to promote the carboxylation of GO from sur-
face hydroxyl and epoxide groups diminishes the intensity of the peak
of the C 1s spectrum associated to C O groups (at 286.3eV). Thus, the
high intensity of this peak after the pegylation process indicates success-
ful incorporation of PEG-diamine. Finally, zeta-potential analysis was
carried out to evaluate the surface charge of the nGO sheets. According
to previously published data [38], the zeta-potential of chemically ac-
tivated nGO sheets with COOH surface groups is −37.8±8mV. Af-
ter the pegylation process, the zeta-potential value changed slightly to
−32±6mV, which confirms the existence of the positive amino ended
branches.
3.2. Cell uptake of pegylated nGO sheets and cell proliferation studies
Uptake of the pegylated nGO sheets and its effects on the pro-
liferation and viability of human osteosarcoma Saos-2 cells were
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Fig. 1. Characterization of pegylated nGO sheets. (A) AFM topographic image of dispersed nGO sheets. The graph represents the thickness profile obtained from the white line of the AFM
image. (B) nGO sheets particle size distribution obtained by DLS. (C) C1s XPS spectra obtained from nGO sheets.
evaluated after 24h of incubation with 75μg/mL of nGO. The internal-
ization of pegylated nGO was confirmed by flow cytometry, after adding
trypan blue to quench the fluorescence produced by the nGO adsorbed
on the outer surface of cells (Fig. 2, orange fluorescence profile) [42].
As it can be observed, similar fluorescence profiles were obtained
with and without trypan blue (orange and blue profiles, respectively),
indicating that pegylated nGO sheets with 300nm size
Fig. 2. Cell uptake of pegylated nGO sheets by human Saos-2 cells: fluorescence profiles
of Saos-2 osteoblasts cultured for 24h with nGO (Saos+nGO) compared to control cells in
absence of nanomaterial (Saos); the exterior cell surface fluorescence was quenched with
trypan blue. (For interpretation of the references to color in this figure legend, the reader
is referred to the web version of this article.)
and a surface charge of −32mV were completely internalized by hu-
man Saos-2 osteoblasts after 24h of treatment. Confocal microscopy was
additionally carried out to evaluate the Saos-2 morphology in the pres-
ence of pegylated nGO sheets and to study its intracellular localization.
The results (Fig. S1) highlight that these pegylated nGO sheets have
been internalized by Saos-2 osteoblasts and were dispersed throughout
the cytoplasm, preferentially localized in the perinuclear area, as indi-
cated by arrows. The particles were clearly outside the nucleus and no
signs of nuclear shrinkage (pyknosis) were apparent. These results are
in agreement with those published by other authors, where most of the
GO that entered cells distributed in the cytoplasm with very few par-
ticles being present in the nucleus [43,44]. Entrapment of nGO sheets
in the lysosomes has also been reported [45,46]. For instance, Li and
co-workers found that GO nanoassemblies were mainly distributed in
acidic lysosomes of mouse embryonic fibroblasts (MEF) after their in-
ternalization [45]. Also, others have shown that, following lysosomal
uptake, a small proportion of graphene could relocate to the cytosol
and interact with the mitochondria [47,48]. The cytoskeleton is an-
other key cellular component reported to interact with graphene-related
nanomaterials. Matesanz and co-workers have shown GO nanosheets
to localize on F-actin filaments of Saos-2 osteoblasts, and to affect
cell cycle and death in a cytoskeleton-dependent manner [49]. Also,
nGO was reported to cause disruption of F-actin cytoskeletal assem-
bly within the lamellipodia of MDA-MB-231 breast cancer cells, thus
impairing cell migration [47]. As for the uptake mechanism, although
this was not assessed in the present study, it has been previously re-
ported that Saos-2 cells take up these pegylated nGO sheets mainly by
macropinocytosis, although microtubule-dependent pathways may also
be involved, without causing any morphological changes [50]. More-
over, Chartterjee and co-workers demonstrated that GO enters the cell
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through clathrin-mediated endocytosis as well as macropinocytosis
[51].
The results obtained for viability and proliferation of human Saos-2
osteoblasts upon 24h nGO treatment are shown in Fig. 3. High per-
centages of viability were obtained in all experimental conditions (97
and 93% in control and nGO-treated cells, respectively) and no sig-
nificant differences were observed (Fig. 3A). With respect to the ef-
fect of nGO treatment on Saos proliferation (Fig. 3B), a significant de-
lay in cell proliferation was observed, which is in agreement with pre-
vious results [49]. The high cell viability observed for nGO-exposed
cells indicates that the plasma membrane integrity was highly pre-
served during the nano-bio interaction and subsequent nGO internal-
ization by Saos-2 cells. This is in contrast with other studies where
graphene and graphene-based nanomaterials were shown to alter the
dynamics and integrity of the plasma membrane during their inter-
nalization, inducing cell death [52]. Some authors suggested that the
serious membrane disruption could be attributed to the strong elec-
trostatic interactions between the graphene surface and the lipid bi-
layer of the cell membrane [53]. Others revealed that certain types of
graphene, such as pristine graphene, could impair cell membrane in-
tegrity by regulation of membrane- and cytoskeleton-associated genes
[54]. In the present study, the absence of membrane damage is likely
due to surface functionalization of the nGO sheets by the non-toxic and
non-immunogenic polymer PEG [55]. Indeed, this corroborates a pre-
vious study addressing the influence of nGO pegylation, whereby 1-
arm pegylated nGO showed high internalization and little interference
with membrane integrity of Saos-2 and several other cell types [38].
As for the proliferation delay observed after nGO internalization
(Fig. 3B), the results are in agreement with those published by other
authors, where a cytotoxicity evaluation of graphene oxide on differ-
ent cells types was carried out [56–58]. The possible mechanism in-
volved in the Saos-2 osteoblasts proliferation delay could be related to
mitogen-activated protein kinases (MAPKs). It is well established that
such kinases are involved in the regulation of cell growth, prolifera-
tion, migration and apoptosis [59]. Matesanz and co-workers reported
that nGO sheets were localized on F-actin filaments of Saos-2 osteoblasts
after their internalization, and thus altered cell cycle in a cytoskele-
ton-dependent manner [49]. Moreover, Tian and co-authors have re-
cently published that nGO sheets retard cellular migration via disruption
of actin cytoskeleton [60]. Therefore, considering that proliferation is
dependent on the cell-cycle progress, it maybe suggested that the uptake
of our graphene oxide nanosheets could induce cell-cycle alterations,
which would cause the proliferation delay observed.
3.3. Metabolic response to nGO uptake and NIR laser irradiation
The metabolic composition of human Saos-2 osteosarcoma cells was
assessed by HRMAS ⁠1H NMR analysis of lysed cell pellets. A representa-
tive cells spectrum is shown in Fig. 4.
Fig. 3. Effect of pegylated nGO sheets on the viability percentage (A) and proliferation (B) of human Saos-2 osteosarcoma cells after 24h of treatment. Statistical significance *p<0.05.
Fig. 4. 500MHz HRMAS ⁠1H NMR spectrum of human Saos-2 osteosarcoma cells, with some assigned metabolites indicated. AMP: adenosine monophosphate, BCAA: branched chain amino
acids (valine, leucine and isoleucine), Cr: creatine, Glu: glutamate, GSH: glutathione, Lac: lactate, m-Ino: myo-inositol, PC: phosphocholine, PCr: phosphocreatine, Phe: phenylalanine,
Tau: taurine, Thr: threonine, Tyr: tyrosine, UDP: uridine diphosphate.
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Similarly to what has been reported for other tumor cell
lines [61–64], the signals of several amino acids (e.g., alanine, glu-
tamate, glycine), reduced glutathione (GSH), lactate, creatine,
choline-containing compounds, taurine, myo-inisitol and uridine/
adenosine nucleotides could be unambiguously identified. Phospho-
choline was one of the most abundant metabolites detected, likely re-
flecting the high malignancy of the Saos-2 cell line, since this metabo-
lite is considered a biomarker of tumor malignant transformation [65].
Other metabolites closely related to tumor progression, such as choline
and creatine (reported to be inversely expressed in later stages of tumor
growth), were also clearly detected. On the other hand, glucose was ab-
sent from the Saos-2 metabolic profile, in agreement with the composi-
tion reported for osteosarcoma [66] and other tumor cell lines [61]. In
non-tumor cells, the glucose flux through the glycolytic pathway is reg-
ulated to maintain a constant concentration of adenosine triphosphate
(ATP). By contrast, glucose uptake and glycolysis are known to occur
nearly 10 times faster in most solid tumors compared with normal tis-
sues [67], explaining the absence of this important metabolite in tumor
cells.
To assess the impact of nGO uptake and laser irradiation on the
metabolic profile of Saos-2 cells, multivariate analysis was applied to
the spectra collected for the three sample groups, i.e. controls cells,
nGO-exposed cells (nGO) and nGO-exposed and laser irradiated cells
(nGO+laser). The resulting PCA scores scatter plot (Fig. 5A) showed
that control and nGO-exposed cells were reasonably clustered and sep-
arated from each other (along the PC2 axis), while the laser-irradi-
ated samples were more scattered, reflecting higher intra-group vari-
ability. Still, by applying PLS-DA, it was possible to discriminate the
three sample groups along LV1 and LV2 axes (Fig. 5B) and to highlight
the main metabolites accounting for such discrimination based on the
corresponding loadings profiles (Fig. 5C and D). According to these pro-
files,
nGO samples differed from controls in the levels of uridine nu-
cleotides, alanine, glutamine, glycine, taurine and creatine (Fig. 5C),
while laser-irradiated samples were discriminated based on higher lev-
els of glycerophosphocholine and AMP, together with lower levels of
creatine and glutamate (Fig. 5D).
Spectral integration of individual metabolite signals was then carried
out to assess the magnitude and statistical significance of the variations
highlighted through multivariate analysis. The most relevant changes
(absolute effect size >0.8, as justified in reference 41) are summarized
in Fig. 6.
In comparison to control cells, Saos-2 cells exposed to nGO showed
consistent alterations in 10 metabolites (first column of the heatmap
shown in Fig. 6), namely decreases in taurine (−44%), glutamine
(−35%), alanine (−34%), creatine (−33%), glycine (−26%), methio-
nine (−25%) and glutamate (−15%), together with increases in phos-
phocholine (+24%), uridine nucleotides (+44%) and AMP (+59%). As
for the effects of laser irradiation, compared to nGO-exposed cells, cells
irradiated after nGO uptake showed higher levels of glycerophospho-
choline (+38%) and AMP (+82%), together with decreased levels of
glutamate (−34%) and uridine nucleotides (−20%) (second column of
the heatmap shown in Fig. 6).
One of the main metabolic alterations displayed by Saos-2 cells upon
nGO uptake and subsequent laser irradiation was a cumulative increase
in the levels of AMP, suggesting that cellular energetic homeostasis
was affected. The impact of graphene on mitochondrial function and
energy production has been previously reported for other cell types
[47,68,69]. For instance, in liver HepG2 cells, nGO sheets (400nm)
were reported to cause dysregulation of mitochondrial Ca⁠2+ home-
ostasis and a decrease in mitochondrial membrane potential (MMP),
which is crucial for ATP synthesis [68]. In
another work, pegylated nGO sheets in the 100–200nm size range were
shown to interact with the mitochondria of MDA-MB-231 breast tu-
mor cells and to reduce ATP generation, possibly in relation with the
down-regulation of enzymes involved in the TCA cycle and oxidative
phosphorylation [47]. Moreover, in mouse alveolar macrophages, GO
has been proposed to participate in redox reactions with components of
the mitochondrial electron transport chain, thereby leading to impair-
ment of ATP production [69]. In the present study, ATP was not clearly
detected in the ⁠1H NMR spectra, possibly due its rapid turnover. Still,
the observed accumulation of AMP could be an indirect indication of en-
ergy shortage, reflecting the attempt of adenylate kinase to rescue ATP
from ADP, with the concomitant production of AMP. Indeed, increased
ATP turnover and depletion of energy reservoirs have also been high-
lighted as hyperthermia-related effects due to increased metabolic rates
[70]. In turn, a high level of AMP is recognized as an efficient activator
of the AMP-activated protein kinase (AMPK), which is a crucial sensor
of cellular energy status [71].
Upon activation, AMPK acts to restore energy homeostasis by stim-
ulating catabolic reactions, while inhibiting ATP-consuming anabolic
processes [71]. Interestingly, in the present study, the metabolic re-
sponse to nGO comprised a consistent decrease in the levels of sev-
eral amino acids, all of which could be used as anaplerotic substrates
for the tricarboxylic acid (TCA) cycle, presumably to increase energy
production. Upon laser irradiation, nGO-exposed cells further decreased
their glutamate levels, while the other amino acids levels (alanine, glu-
tamine, methionine) remained similar to non-irradiated nGO-exposed
cells. Moreover, nGO-internalizing cells showed decreased levels of cre-
atine (synthetized from arginine and glycine), which could also re-
late to the impact of nGO on amino acid metabolism. On the other
hand, phosphocholine registered a relevant increase in nGO-internal-
izing cells in relation to controls. As phosphocholine is central to the
synthesis of the major cell membrane component phosphatidylcholine,
its increment may reflect the down-regulation of phospholipid synthe-
sis, in consonance with the putative AMPK-mediated inhibition of ana-
bolic processes. This also agrees with the proliferation delay displayed
by nGO-exposed Saos-2 cells (Fig. 3B). Altogether, the metabolic varia-
tions described above suggest that AMPK activation may be an impor-
tant player in the cellular responses to nGO and nGO-mediated hyper-
thermia, a hypothesis which needs to be verified in further studies.
Laser-irradiated cells further showed an increase in glycerophospho-
choline, a well-known membrane breakdown product, likely reflecting
heat-induced membrane damage [72]. Indeed, previous results demon-
strated that nGO mediated hyperthermia under similar conditions to
those applied in this study (low power and 7min of laser exposure)
caused Saos-2 osteoblasts death by mixed apoptotic/necrotic process,
implying loss of the plasma membrane integrity [30]. Notably, glyc-
erophosphocholine levels did not vary upon nGO uptake in the absence
of laser treatment, in agreement with the preservation of membrane in-
tegrity in non-irradiated nGO-internalizing cells (Fig. 3A).
As taurine is an antioxidant metabolite [73], its decrease upon
nGO uptake could be related to nanomaterial-induced oxidative stress.
However, while the generation of reactive oxygen species (ROS) has
been reported to be a common response to graphene-based nanomate-
rials [44,51], previous results from our group have shown that pegy-
lated nGO sheets of similar size did not increase ROS in Saos-2 cells
[49]. Moreover, glutathione, another important antioxidant metabo-
lite clearly detected in the cells profile, did not vary upon nGO up-
take, corroborating the absence of a strong oxidative stress response.
Therefore, taurine variation likely relates to other possible roles of
this metabolite, such as in osmoregulation,
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Fig. 5. Multivariate analysis of human Saos-2 osteosarcoma cells spectra. (A) PCA scores plot, (B) PLS-DA scores plot (C) PLS-DA LV2 loadings: Ct vs. nGO. (D) PLS-DA LV1 loadings: nGO
vs. nGO+laser.
membrane stabilization, calcium homeostasis or protein phosphoryla-
tion [74].
Finally, nGO-internalizing cells showed increased levels of uridine
nucleotides, which subsequently decreased after laser irradiation. The
bioavailability of uridine is particularly crucial to the synthesis of RNA
and biomembranes (via the formation of pyrimidine nucleotide–lipid
conjugates), being also needed for the formation of UDP-sugar conju-
gates involved in the post-translational modification of proteins [75].
Therefore, the observed variations may possibly relate to the effects of
nGO and hyperthermia on cell proliferation and/or protein glycosyla-
tion.
4. Conclusions
Pegylated nGO sheets with a hydrodynamic size of 300nm were
taken up by human Saos-2 osteosarcoma cells without impairing cell
viability, while causing a delay in cell proliferation. At the metabolic
level, nGO produced consistent variations in several metabolites, mainly
reflecting changes in energy homeostasis. In particular, based on in-
creased levels of AMP and phosphocholine, together with decreases
in several amino acids, we have newly hypothesized that AMPK ac-
tivation may be an important player in
7
UN
CO
RR
EC
TE
D
PR
OO
F
M. Cicuéndez et al. Materials Science & Engineering C xxx (2018) xxx-xxx
Fig. 6. Heatmap of main metabolic variations after nGO uptake by human Saos-2 os-
teoblasts (nGO vs. Ct) and after NIR laser irradiation at 1.5W/cm⁠2 power during 5min
(nGO+Laser vs. nGO). Statistical significance **p<0.01.
the cellular responses to nGO. Notably, subsequent laser irradiation of
nGO-internalizing cells produced fewer effects: changes in AMP and
glutamate were amplified, the levels of uridine nucleotides recovered
and glycerophosphoholine increased, this latter change likely reflecting
laser-induced membrane damage. Overall, this study has shown that cel-
lular metabolome sensitively responded to nGO exposure and nGO-me-
diated hyperthermia, and that NMR metabolomics is a powerful tool in
nanotoxicity studies, allowing for new hypotheses on molecular mech-
anisms underlying treatment responses to be generated. Furthermore,
knowledge on the thermosensitivity of metabolite changes may be im-
portant to modulate cell killing by hyperthermia in future works.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.msec.2018.05.057.
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As it can be observed, similar fluorescence profiles were obtained
with and without trypan blue (orange and blue profiles, respectively),
indicating that pegylated nGO sheets with 300nm size and a surface
charge of −32mV were completely internalized by human Saos-2 os-
teoblasts after 24h of treatment. Confocal microscopy was addition-
ally carried out to evaluate the Saos-2 morphology in the presence of
pegylated nGO sheets and to study its intracellular localization. The
results (Fig. Fig. S1) highlight that these pegylated nGO sheets have
been internalized by Saos-2 osteoblasts and were dispersed throughout
the cytoplasm, preferentially localized in the perinuclear area, as in-
dicated by arrows. The particles were clearly outside the nucleus and
no signs of nuclear shrinkage (pyknosis) were apparent. These results
are in agreement with those published by other authors, where most
of the GO that entered cells distributed in the cytoplasm with very
few particles being present in the nucleus [43,44]. Entrapment of nGO
sheets in the lysosomes has also been reported [45,46]. For instance,
Li and co-workers found that GO nanoassemblies were mainly distrib
uted in acidic lysosomes of mouse embryonic fibroblasts (MEF) af-
ter their internalization [45]. Also, others have shown that, follow-
ing lysosomal uptake, a small proportion of graphene could relocate
to the cytosol and interact with the mitochondria [47,48]. The cy-
toskeleton is another key cellular component reported to interact with
graphene-related nanomaterials. Matesanz and co-workers have shown
GO nanosheets to localize on F-actin filaments of Saos-2 osteoblasts,
and to affect cell cycle and death in a cytoskeleton-dependent manner
[49]. Also, nGO was reported to cause disruption of F-actin cytoskeletal
assembly within the lamellipodia of MDA-MB-231 breast cancer cells,
thus impairing cell migration [47]. As for the uptake mechanism, al-
though this was not assessed in the present study, it has been previously
reported that Saos-2 cells take up these pegylated nGO sheets mainly
by macropinocytosis, although microtubule-dependent pathways may
also be involved, without causing any morphological changes [50].
Moreover, Chartterjee and co-workers demonstrated that GO enters the
cell through clathrin-mediated endocytosis as well as macropinocytosis
[51].
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